Asthma Trial, Recruiting NCT07431021 Sponsor: Queen Mary University of London Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT07431021
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who attend schools in Central and East London that have been recruited to take part in this study

Who may not be able to join:

  • Children who are unable to safely take part in physical education (PE) lessons, as reported by their parents
  • Children whose learning or physical disabilities mean they are unable to give their agreement to take part in the study or carry out the study activities

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: James Scales, PhD, Queen Mary University London

Phone: +447533897264

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Queen Mary University of London
Registry
ClinicalTrials.gov
Start date
20 October 2025
Est. completion
1 July 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

"Airway resistance" measured by Oscillometry at R5

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov